John Overdeck’s Axonics, Inc. Common Stock AXNX Stock Holding History

John Overdeck’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,700	Closed	-$319K	–	4596
2021 Q4	$319K	Sell	5,700 -4,600	-45%	-$281K	﹤0.01%	3605
2021 Q3	$670K	Buy	10,300 +4,300	+72%	+$293K	﹤0.01%	2999
2021 Q2	$380K	Sell	6,000 -4,000	-40%	-$236K	﹤0.01%	3316
2021 Q1	$599K	Buy	+10,000	New	+$544K	﹤0.01%	2764

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

John Overdeck's AXNX Position: Q2 2023 in Review

John Overdeck sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2023, closing a stake of 81,605 shares — an estimated $4.45M sold.

John Overdeck first reported a position in AXNX in Q3 2019 and held it in 8 quarters. The position peaked at $9.8M in Q3 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2023.

John Overdeck reported no remaining Axonics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
John Overdeck sold 81,605 Axonics, Inc. Common Stock shares in Q2 2023, an estimated $4.45M.
John Overdeck first reported a position in Axonics, Inc. Common Stock in Q3 2019 and held it in 8 quarters.
John Overdeck's Axonics, Inc. Common Stock position peaked at $9.8M in Q3 2022.
235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.